Peptide And Oligonucleotide Cdmo Market Scope And Analysis

  • Report Code : TIPRE00040673
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Peptide And Oligonucleotide CDMO Market Analysis, Size, and Growth (2025-2031)

Buy Now

Peptide And Oligonucleotide CDMO Market Report Peptide And Oligonucleotide CDMO Market Size and Share Peptide And Oligonucleotide CDMO Market Scope and Analysis

Peptide And Oligonucleotide CDMO Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 12.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Peptides
  • Oligonucleotides
By Service Type
  • Contract Development
  • Contract Manufacturing
By End Use
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • PolyPeptide Group
  • STA Pharmaceutical Co Ltd
  • Bachem
  • Creative Peptides
  • Aurigene Pharmaceutical Services Ltd
  • Merck KGaA
  • EUROAPI
  • Curia Global Inc
  • CordenPharm
  • Sylentis S A